Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion

Circulation Research

Volumn 78, Issue 1, 1996, Pages 65-72

  Pabla, Ravinder ^b   Buda, Andrew J ^a   Flynn, David M ^a   Blessé, Steven A ^a   Shin, Alice M ^a   Curtis, Michael J ^b   Lefer, David J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

ischemia; L arginine; N(G) nitro L arginine methyl ester; nitric oxide; reperfusion

Indexed keywords

ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG EFFECT; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; INFLAMMATORY INFILTRATE; MALE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0030025202     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.78.1.65     Document Type: Article

References (35)

1. Sheridan FM, Dauber IM, McMurtry IF, Lesnefsky EJ, Horwitz LD. Role of leukocytes in coronary vascular endothelial injury due to ischemia and reperfusion. Circ Res. 1991;69:1566-1574.
2. Tsao PS, Ma X-L, Leter AM. Activated neutrophils aggravate endothelial dysfunction after reperfusion of the ischemic feline myocardium. Am Heart J. 1992;123:1464-1471.
3. Lucchesi BR, Mullane KM. Leukocytes and ischemia-induced myocardial injury. Ann Rev Pharmacol Toxicol. 1986;26:201-224.
4. Engler RL, Schmid-Schönbein GW, Pavelec RS. Leukocyte plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol. 1983;111:98-111.
5. Myers ML, Webb C, Moffat M, McIver D, Maestro RD. Activated neutrophils depress myocardial function in the perfused rabbit heart. Can J Cardiol. 1991;7:323-330.
6. Engler R, Covell JW. Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog. Circ Res. 1987;61: 20-28.
7. Westlin W, Mullane K. Alleviation of myocardial stunning by leukocyte and platelet depletion. Circulation. 1989;80:1828-1836.
8. Lefer DJ, Shandelya SML, Serrano CV, Becker LC, Kuppusamy P, Zweier JL. Cardioprotective actions of a monoclonal antibody against CD-18 in myocardial ischemia-reperfusion injury. Circulation. 1993;88:1779-1787.
9. Byrne JG, Smith WJ, Murphy MP, Couper GS, Appleyard RF, Cohn LH. Complete prevention of myocardial stunning, contracture, low-reflow, and edema after heart transplantation by blocking neutrophil adhesion molecules during reperfusion. J Thorac Cardiovasc Surg. 1992;104:1589-1596.
10. O'Neill PG, Charlat ML, Michael LH, Roberts R, Bolli R. Influence of neutrophil depletion on myocardial function and flow after reversible ischemia. Am J Physiol. 1989;256:H341-H351.
11. 2 fragments of anti-Mol (904) monoclonal antibodies do not prevent myocardial stunning. Circ Res. 1989;65:1112-1124.
12. Jeremy RW, Becker LC. Neutrophil depletion does not prevent myocardial dysfunction after brief coronary occlusion. J Am Coll Cardiol. 1989;13:1155-1163.
13. Juneau CF, Ito BR, Balzo UD, Engler RL. Severe neutrophil depletion by leukocyte filters of cytotoxic drug does not improve recovery of contractile function in stunned porcine myocardium. Cardiovasc Res. 1993;27:720-727.
14. Grygleski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. Lond. 1986;320:454-456.
15. Hasebe N, Shen Y-T, Vatner SF. Inhibition of endothelium-derived relaxing factor enhances myocardial stunning in conscious dogs. Circulation. 1993;88:2862-2871.
16. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992;257:387-389.
17. Weyrich AS, Ma X-L, Buerke M, Murohara T, Armstead VE, Lefer AM, Nicolas JM, Thomas AP, Lefer DJ, Vinten-Johansen J. Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res. 1994; 75:692-700.
18. Ma X-L, Weyrich AS, Lefer DJ, Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res. 1993;72: 403-412.
19. Bochner BS, MacGlashan DW Jr, Marcotte GV, Schleimer RP. IgE-dependent regulation of human basophil adherence to vascular endothelium. J Immunol. 1989;142:3180-3186.
20. Schleimer RP, Rutledge BK. Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin-1, endotoxin, and tumor-promoting phorbol esters. J Immunol. 1986;136:649-654.
21. Spath JA, Lane DL, Lefer AM. Protective action of methylprednisolone of the myocardium during experimental ischemia in the cat. Circ Res. 1974:35:44-51.
22. x analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion. Circulation. 1994: 90:2390-2401.
23. Weyrich AS, Ma X-L, Lefer AM. The role of L-arginine in amelio-rating reperfusion injury after myocardial ischemia in the cat. Circulation. 1992;86:279-288.
24. Nakanishi K, Vinten-Johansen J, Lefer DJ, Zhao Z, Fowler WC, McGee DS, Johnston WE. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol. 1992;263:H1650-H1658.
25. Siegfried MR, Carey C, Ma X-L, Lefer AM. Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. Am J Physiol. 1992;263:H771-H777.
26. Lefer DJ, Nakanishi K, Johnston WE, Vinten-Johansen J. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation. 1993;88:2337-2350.
27. Brady AJ, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol. 1993;265:H176-H182.
28. Amrani M, O'Shea J, Allen NJ, Harding SE, Jayakumar J, Pepper JR, Moncada S, Yacoub MH. Role of basal release of nitric oxide on coronary flow and mechanical performance of the isolated rat heart. J Physiol. 1992;456:681-687.
29. Gillespie MN, Kojima S, Kunitomo J, Jay M. Coronary and myocardial effects of activated neutrophils in perfused rabbit hearts. J Pharmacol Exp Ther. 1986;239:836-840.
30. Kraemer R, Smith CW, Mullane KM. Activated human polymorphonuclear leukocytes reduce rabbit papillary muscle function: role of the CD 18 glycoprotein adhesion complex. Cardiovasc Res. 1991;25:172-175.
31. Kubes P, Granger DN. Nitric oxide modulates microvascular permeability. Am J Physiol. 1992;262:H611-H615.
32. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991; 88:4651-4655.
33. Gauthier TW, Davenpeck KL, Lefer AM. Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol. 1994;267:G562-G568.
34. Lefer DJ, Klunk DA, Lutty GA, Merges C, Schleimer RP, Bochner BS, Zweier JL. Nitric oxide (NO) donors reduce basal ICAM-1 expression on human aortic endothelial cells (HAECs). Circulation. 1993;88:3037. Abstract.
35. Niu X, Smith CW, Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res. 1994;74:1133-1140.